Complement factor D in age-related macular degeneration

Citation for published version: Stanton, CM, Yates, JRW, den Hollander, AI, Seddon, JM, Swaroop, A, Stambolian, D, Fauser, S, Hoyng, C, Yu, Y, Atsuhiro, K, Branham, K, Othman, M, Chen, W, Kortvely, E, Chalmers, K, Hayward, C, Moore, AT, Dhillon, B, Ueffing, M & Wright, AF 2011, 'Complement factor D in age-related macular degeneration' Investigative Ophthalmology & Visual Science, vol 52, no. 12, pp. 8828-34. DOI: 10.1167/iovs.11-7933

[1]  M. Daly,et al.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[2]  C. Bunce,et al.  Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008 , 2010, Eye.

[3]  Aaron Y. Lee,et al.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.

[4]  Margaret A. Pericak-Vance,et al.  Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.

[5]  Don H. Anderson,et al.  The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in Retinal and Eye Research.

[6]  J. Seddon,et al.  Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.

[7]  Martin Oppermann,et al.  Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.

[8]  G. Abecasis,et al.  Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. , 2007, Human molecular genetics.

[9]  L. Sobrin,et al.  Review of Genetics in Age Related Macular Degeneration , 2007, Seminars in ophthalmology.

[10]  M. Abney,et al.  The sex-specific genetic architecture of quantitative traits in humans , 2006, Nature Genetics.

[11]  G. Fantuzzi.  Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[12]  J. Miner.  The adipocyte as an endocrine cell. , 2004, Journal of animal science.

[13]  L. Lönn,et al.  High expression of complement components in omental adipose tissue in obese men. , 2003, Obesity research.

[14]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[15]  S. Narayana,et al.  Structural biology of the alternative pathway convertase , 2001, Immunological reviews.

[16]  L. DeLucas,et al.  Structural basis of profactor D activation: from a highly flexible zymogen to a novel self‐inhibited serine protease, complement factor D , 1999, The EMBO journal.

[17]  B. Pussell,et al.  Detection and quantification of the control proteins of the alternative pathway of complement in 3T3‐L1 adipocytes , 1997, European journal of clinical investigation.

[18]  P. Gasque,et al.  Extrahepatic complement biosynthesis: where, when and why? , 1997, Clinical and experimental immunology.

[19]  S. Narayana,et al.  Complement factor D, a novel serine protease , 1996, Protein science : a publication of the Protein Society.

[20]  J. Volanakis,et al.  Recombinant and native zymogen forms of human complement factor D. , 1994, Journal of immunology.

[21]  B. Spiegelman,et al.  Adipsin and an endogenous pathway of complement from adipose cells. , 1992, The Journal of biological chemistry.

[22]  B. Spiegelman,et al.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. , 1992, The Journal of biological chemistry.

[23]  J. Volanakis,et al.  Metabolism of complement factor D in renal failure. , 1988, Kidney international.

[24]  B. Spiegelman,et al.  A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Barnum,et al.  In vitro biosynthesis of complement protein D by U937 cells. , 1985, Journal of immunology.

[26]  J. Kearney,et al.  Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. , 1984, Journal of immunological methods.

[27]  K. Whaley.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes , 1980, The Journal of experimental medicine.

[28]  H. Müller-Eberhard,et al.  Mechanism of action of factor D of the alternative complement pathway , 1978, The Journal of experimental medicine.

[29]  R. Schreiber,et al.  Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins , 1978, The Journal of experimental medicine.

[30]  D. Fearon,et al.  PROPERDIN FACTOR D: CHARACTERIZATION OF ITS ACTIVE SITE AND ISOLATION OF THE PRECURSOR FORM , 1974, The Journal of experimental medicine.

[31]  Frank Eperjesi,et al.  Risk Factors for Age-related Macular Degeneration , 2011 .

[32]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[33]  Finland.,et al.  First of two parts , 2001 .